Nifty Pharma Today: Index Gains 0.72% in Closing Bell

Updated: 31 Aug 2026 • 4:17 pm

Posted by:

Nifty Pharma Today: Index Gains 0.72% in Closing Bell

Quick sector takeaways

Nifty Pharma ended 194.60 points, or 0.72%, higher at 27,186.45, compared with its previous close of 26,991.85.
The index moved between 26,713.10 and 27,188.45 during the session and finished just 2 points below its day high.
Breadth was mixed: 9 of 20 display-safe stocks advanced while 11 declined, showing that the sector’s positive close was not broad-based.
Aurobindo Pharma, Sun Pharmaceutical Industries and Divi’s Laboratories were among the notable gainers, while JB Chemicals & Pharmaceuticals, Zydus Lifesciences and Dr. Reddy’s Laboratories declined. The next session will test whether the index can retain its firm closing position.

In this end-of-session wrap for nifty pharma today, the sector index emerged as the second top gainer among the configured sector indices on 31 August 2026. The closing data was last updated at 4:15:01 PM IST.

Nifty Pharma today: a positive close with selective participation

Nifty Pharma closed at 27,186.45, up 194.60 points from the previous close of 26,991.85. The 0.72% gain placed the index behind only Nifty Bank among the configured sector indices for the day. The index opened at 27,001.85, marginally above the prior close, slipped to an intraday low of 26,713.10, and then recovered decisively to finish near the session high.

The close near the day’s peak is a straightforward indication that the index regained ground after the intraday low. However, the underlying stock picture was divided, with decliners outnumbering advancers. That contrast makes the index-level rise notable: strength in a select group of pharma stocks was sufficient to lift the sector benchmark despite more stocks ending lower.

Price snapshot

The index’s LTP stood at 27,186.45, against a previous close of 26,991.85. This translates into an absolute gain of 194.60 points and a percentage rise of 0.72%. Its day high was 27,188.45 and its day low was 26,713.10, a range of 475.35 points.

At the close, Nifty Pharma was only 2.00 points below its intraday high. It was also 184.60 points above the opening level of 27,001.85. These figures describe a session in which the index moved from an early dip to a firm finish, while remaining within the day’s established range.

Sector ranking

Nifty Pharma was the second top gaining sector index in the configured set, rising 0.72%. Nifty Bank led the gains with a 0.92% increase, while Nifty Mid Select gained 0.41% and Nifty Financial Services added 0.03%. In contrast, Nifty IT fell 0.29%, Nifty Auto slipped 0.04%, Nifty FMCG declined 1.69%, and Nifty Metal dropped 2.45%.

This ranking reflects the actual closing move of each index in the configured group. For Nifty Pharma, the 0.72% advance was therefore a meaningful relative performance result within this sector-index comparison, even as the constituents showed a mixed distribution of daily returns.

Constituent breadth

Of the 20 display-safe Nifty Pharma stocks, 9 advanced and 11 declined, with none unchanged. The advance-decline ratio was 0.82, meaning that for every advancing stock there were roughly 1.22 declining stocks. Breadth was thus negative even though the index ended in positive territory.

This difference between the headline index move and stock-level breadth is important for readers tracking nifty pharma today. It shows that the sector’s gain was selective rather than evenly spread across the basket. The strong moves in some stocks coincided with declines in several others, leaving the index higher but participation uneven.

Heavyweights versus broader participation

Among the listed heavyweight stocks, Sun Pharmaceutical Industries rose 3.37% to Rs. 1,984.80, while Divi’s Laboratories gained 2.47% to Rs. 9,467.00. Torrent Pharmaceuticals added 0.32% to Rs. 5,066.00. On the other side, Cipla fell 1.00% and Dr. Reddy’s Laboratories declined 2.00%.

The supplied active-stock list also included Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla and Dr. Reddy’s Laboratories. Within this group, the positive moves in Sun Pharma and Divi’s Laboratories stood alongside declines in Cipla and Dr. Reddy’s, reinforcing the mixed but selectively strong closing pattern across the sector.

Key Nifty Pharma stocks

Stock	Move	Why it matters
Aurobindo Pharma	+4.36% to Rs. 1,717.00	It was the leading percentage gainer among the supplied sector stocks and closed at its day high.
Sun Pharmaceutical Industries	+3.37% to Rs. 1,984.80	Its strong gain featured within the supplied heavyweight and active-stock lists.
Divi’s Laboratories	+2.47% to Rs. 9,467.00	It closed at its day high and was included among the supplied heavyweight and active stocks.
JB Chemicals & Pharmaceuticals	-3.87% to Rs. 2,408.90	It was the largest percentage decliner among the supplied sector stocks.
Zydus Lifesciences	-2.49% to Rs. 1,161.30	Its decline was among the sharper negative moves in the sector.

Biggest positive movers

Aurobindo Pharma led the gainers, rising 4.36% to Rs. 1,717.00 after trading between Rs. 1,635.10 and Rs. 1,717.00. Sun Pharmaceutical Industries followed with a 3.37% increase to Rs. 1,984.80, also closing at its day high. Divi’s Laboratories added 2.47% to Rs. 9,467.00 and likewise finished at the session high.

Mankind Pharma advanced 1.52% to Rs. 2,419.20, while Ipca Laboratories and Ajanta Pharma each gained 1.26%. These positive movers supplied the strongest upward individual returns within the sector’s closing landscape.

Biggest negative movers

JB Chemicals & Pharmaceuticals was the steepest decliner, falling 3.87% to Rs. 2,408.90. Zydus Lifesciences declined 2.49% to Rs. 1,161.30, while Dr. Reddy’s Laboratories fell 2.00% to Rs. 1,154.40 and closed at its day low.

Natco Pharma lost 1.44% to Rs. 841.50, and Glenmark Pharmaceuticals declined 1.39% to Rs. 2,480.00. Other negative closes included Abbott India, Laurus Labs, Cipla, Granules India, Alkem Laboratories and Gland Pharma. Their combined presence explains why the sector’s breadth remained tilted towards decliners despite the index gain.

Stocks to watch next session

Aurobindo Pharma: closed at Rs. 1,717.00, its day high, after a 4.36% gain.
Sun Pharmaceutical Industries: finished at Rs. 1,984.80, its day high, up 3.37%.
Divi’s Laboratories: ended at Rs. 9,467.00, its day high, gaining 2.47%.
JB Chemicals & Pharmaceuticals: closed at Rs. 2,408.90 after a 3.87% decline.
Zydus Lifesciences: ended at Rs. 1,161.30, down 2.49%.
Dr. Reddy’s Laboratories: finished at Rs. 1,154.40, its day low, after a 2.00% fall.

The constructive case

The constructive evidence is visible in the index close and the performance of several leading gainers. Nifty Pharma rose 0.72%, recovered from the intraday low of 26,713.10, and finished at 27,186.45, just below its day high of 27,188.45. Aurobindo Pharma, Sun Pharmaceutical Industries and Divi’s Laboratories posted gains of more than 2%, while Mankind Pharma also advanced over 1%.

These outcomes gave the index a positive close and placed it second in the configured sector ranking. The position near the day high is an observation of closing strength, while the individual gains show where the day’s positive stock-level momentum was concentrated.

The cautious case

The cautious case rests on breadth. Eleven of the 20 display-safe sector stocks declined, compared with nine advancers. The advance-decline ratio of 0.82 shows that the positive index result was achieved alongside a larger number of falling stocks.

Sharp declines in JB Chemicals & Pharmaceuticals, Zydus Lifesciences and Dr. Reddy’s Laboratories, along with losses in several other stocks, underline this uneven participation. Readers assessing the next session can therefore track whether gains broaden beyond the leading positive movers or whether the divergence between the index and breadth persists.

Univest Insights

Nifty Pharma today delivered a positive closing result of 0.72%, with the index ending at 27,186.45. The session’s high-low range and the near-high close frame the index action as a firm end-of-day recovery from the intraday low.

At the stock level, Aurobindo Pharma, Sun Pharmaceutical Industries and Divi’s Laboratories provided prominent positive moves. Their closing positions at their respective day highs are observations that place them among the session’s strongest performers.

At the same time, breadth remained negative, with 11 declines against 9 advances. This makes it useful to separate the index outcome from the wider constituent distribution rather than treating the sector rise as uniform across all pharma stocks.

Readers can follow the broader market context through Univest Market View and monitor the sector through the Nifty Pharma screener. For traders and investors, the key signal to watch is…

Published on 31 August 2026 at 4:16 PM IST

Frequently asked questions

How did Nifty Pharma close on 31 August 2026?

Nifty Pharma closed at 27,186.45, up 194.60 points or 0.72% from its previous close of 26,991.85.

What were the day high and day low for Nifty Pharma?

The index recorded a day high of 27,188.45 and a day low of 26,713.10.

Why was Nifty Pharma the second top gaining sector index?

Its 0.72% gain was second only to Nifty Bank’s 0.92% rise among the configured sector indices.

How was the breadth in Nifty Pharma stocks?

Of 20 display-safe stocks, 9 advanced and 11 declined, while none remained unchanged.

Which stocks gained the most in Nifty Pharma today?

Aurobindo Pharma rose 4.36%, Sun Pharmaceutical Industries gained 3.37%, and Divi’s Laboratories advanced 2.47%.

Which stocks declined the most in Nifty Pharma today?

JB Chemicals & Pharmaceuticals fell 3.87%, Zydus Lifesciences declined 2.49%, and Dr. Reddy’s Laboratories lost 2.00%.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.